Singapore markets open in 6 hours 44 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,304.83 +58.15 (+1.11%) Dow
39,861.14 +303.03 (+0.77%) Nasdaq
16,739.21 +228.03 (+1.38%) Bitcoin USD
65,138.16 +3,838.66 (+6.26%) CMC Crypto 200
1,374.84 +106.89 (+8.43%)
Sedana Medical AB (publ) (7D2A.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:32AM CEST. Market open.
| Previous close | 1.8900 |
| Open | 1.9360 |
| Bid | 1.9600 x N/A |
| Ask | 2.0650 x N/A |
| Day's range | 1.9360 - 1.9360 |
| 52-week range | 1.1620 - 2.9000 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 201.747M |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings date | 23 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireSedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235 randomized patients remaining. The company anticipates topline results from both trials in the second half of 2024, with a planned New Drug Application (NDA) submission in the first quarter of 2025.
© 2024 Yahoo. All rights reserved.